Live Breaking News & Updates on Day One Biopharmaceuticals Company Profile

Stay updated with breaking news from Day one biopharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) CEO Jeremy Bender Sells 7,873 Shares

Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) CEO Jeremy Bender sold 7,873 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $16.08, for a total transaction of $126,597.84. Following the completion of the sale, the chief executive officer now […] ....

New York , United States , Piper Sandler , Jeremy Bender , York Mellon Corp , Vanguard Group Inc , Goldman Sachs Group , York State Common Retirement Fund , Timessquare Capital Management , Needham Company , Day One Biopharmaceuticals Company Profile , Charles Schwab Investment Management Inc , Day One Biopharmaceuticals Inc , Day One Biopharmaceuticals , Get Free Report , One Biopharmaceuticals , Schwab Investment Management , New York Mellon Corp , Square Capital Management , Day One Biopharmaceuticals Daily ,